Local Anaesthetic Systemic Toxicity (LAST): The Definitive Protocol for Orthopaedic Surgeons

Local anaesthetics are arguably the most commonly used drugs in orthopaedic surgery. As an orthopaedic registrar, you will inject local anaesthetic virtually every single day. From the emergency department manipulation of a distal radius fracture using a haematoma block, to Wide Awake Local Anaesthesia No Tourniquet (WALANT) hand procedures, to high-volume Local Infiltration Analgesia (LIA) for total joint arthroplasties—these medications are the backbone of perioperative pain management.

Because they are ubiquitous, a dangerous level of complacency can naturally set in. We often ask the scrub nurse for "another 20 mils of Marcain" without a second thought. However, Local Anaesthetic Systemic Toxicity (LAST) is a catastrophic, rapidly unfolding physiological event that can lead to intractable seizures, cardiovascular collapse, and cardiac arrest within minutes of administration.

Every surgeon who draws up and injects local anaesthetic must know the "Lipid Rescue" protocol by heart. In the event of a LAST crisis, the anaesthetic team may not be immediately present (especially in the emergency department or minor procedure rooms). You must be prepared to lead the initial resuscitation. This comprehensive guide covers the pharmacology, prevention, early recognition, and definitive management of this life-threatening emergency, tailored specifically for orthopaedic surgery training and fellowship exam preparation.

Visual Element: Diagram showing the "Site Absorption Hierarchy" - ranking injection sites from highest absorption (Intercostal) to lowest (Subcutaneous), emphasizing why site matters as much as dose.

The Core Pharmacology of Local Anaesthetics

To understand toxicity, we must first understand the basic pharmacology. Local anaesthetics (LAs) are broadly divided into two classes based on their chemical linkage: Amides and Esters.

• Amides (e.g., Lignocaine, Bupivacaine, Ropivacaine) are metabolized in the liver by cytochrome P450 enzymes. They are the standard agents used in modern orthopaedic practice. Remember that all amides have an "i" in their prefix (Lignocaine, Bupivacaine).
• Esters (e.g., Tetracaine, Chloroprocaine) are metabolized by plasma pseudocholinesterases. They are rarely used in orthopaedics today due to higher rates of allergic reactions (via the PABA metabolite).

Local anaesthetics work by reversibly binding to the intracellular portion of voltage-gated sodium channels, blocking sodium influx and thereby preventing the depolarization necessary for nerve action potential conduction.

Pathophysiology of LAST

Toxicity occurs when systemic plasma levels of the free (unbound) local anaesthetic rise high enough to indiscriminately block voltage-gated sodium channels in the Brain (triggering excitation followed by depression/seizures) and the Heart (triggering profound arrhythmias and cardiac arrest).

Mechanism of Toxicity:

1. Direct Intravascular Injection: This is the most common cause of acute, catastrophic LAST. It has a rapid onset, typically within seconds to 1 minute of injection.
2. Systemic Absorption: This has a slower, more insidious onset, occurring anywhere from 15 minutes to several hours after injection. It depends heavily on the total dose administered and the inherent vascularity of the injection site.

High-Risk Scenarios in Orthopaedic Practice

LAST does not happen in a vacuum. It usually occurs when pushing the boundaries of safe dosing or when injecting into highly vascular areas without adequate precautions. Certain orthopaedic scenarios carry an inherently higher risk:

1. Local Infiltration Analgesia (LIA) in Arthroplasty

Modern enhanced recovery after surgery (ERAS) protocols for Total Knee Arthroplasty (TKA) and Total Hip Arthroplasty (THA) rely heavily on high-volume LIA. Surgeons routinely inject 100-150 mL of diluted Ropivacaine or Bupivacaine into the posterior capsule, periosteum, and subcutaneous tissues. While the concentration is low (e.g., 0.2%), the absolute milligram dose is massive and often flirts with the maximum toxic threshold. The raw, bleeding cancellous bone cuts in a TKA provide a massive surface area for rapid systemic absorption once the tourniquet is deflated.

2. WALANT Surgery (Wide Awake Local Anaesthesia No Tourniquet)

Pioneered by Dr. Donald Lalonde, WALANT relies on tumescent local anaesthesia (Lignocaine with Adrenaline) to provide a bloodless field without a tourniquet. While generally very safe when using standard protocols (typically 1% Lignocaine with 1:100,000 Adrenaline), hand surgeons frequently operate on multiple digits or perform extensive tenolyses, requiring large volumes. If the surgeon loses track of the total volume injected over a multi-hour case, systemic toxicity can easily occur.

3. Fascia Iliaca and Femoral Nerve Blocks

Often performed by orthopaedic trainees in the emergency department for fractured neck of femur patients, these blocks require large volumes (30-40 mL) to effectively spread across the fascial planes. The proximity to the massive femoral vessels introduces a significant risk of inadvertent direct intravascular injection if ultrasound guidance and rigorous aspiration are not utilized.

Clinical Presentation: The Warning Signs

Classically, the symptoms of LAST follow a predictable progression from Central Nervous System (CNS) excitation, to CNS depression, and finally to Cardiovascular System (CVS) collapse.

However, you must be hyper-vigilant: 20-40% of cases present atypically, with sudden seizure or direct cardiac arrest as the VERY FIRST sign. This atypical presentation is especially common with Bupivacaine or if the patient is under general anaesthesia (which masks the early CNS prodrome).

1. CNS Toxicity (The Warning Shots)

The brain is more sensitive to local anaesthetics than the heart. The inhibitory pathways in the cerebral cortex are blocked first, leading to unopposed excitatory activity.

• Subjective (Prodrome): Metallic taste in the mouth, circumoral numbness (tingling around the lips and tongue), tinnitus (ringing in the ears), lightheadedness, and visual disturbances.
• Objective (Excitation): Confusion, acute agitation, slurred speech, muscle twitching (especially in the face and hands), and tremors.
• The Event: Progression to generalized tonic-clonic Seizures.
• Late CNS: Following the seizure, the excitatory pathways are eventually blocked as well, leading to profound CNS depression, coma, and respiratory arrest (apnoea).

2. CVS Toxicity (The Crash)

Cardiac toxicity is highly lethal and requires immediate, aggressive intervention.

• Early (Excitation): Hypertension and Tachycardia. This is caused by a sympathetic surge and is often the only warning sign in a patient under general anaesthesia.
• Late (Depression): Profound hypotension, bradycardia, and conduction blocks (prolonged PR, widened QRS). The myocardium becomes stunned and unable to pump effectively.
• Terminal: Ventricular arrhythmias (Ventricular Tachycardia / Ventricular Fibrillation) rapidly degrading into Asystole.

Prevention: Calculating the "Safe" Dose

As an orthopaedic surgeon, prevention is your primary responsibility. Calculators and maximum dose charts are guidelines, not guarantees. True toxicity thresholds vary wildly based on individual patient physiology.

Patient Risk Factors that LOWER the Toxicity Threshold:

• Extremes of Age: Neonates and the frail elderly have reduced clearance.
• Low Albumin / Malnutrition: Local anaesthetics are highly protein-bound. Low protein states (liver failure, malnutrition, severe systemic illness) mean more unbound, highly toxic "free drug" circulates in the blood.
• Cardiac Disease: Patients with pre-existing conduction blocks, ischemic heart disease, or heart failure are highly susceptible to CVS collapse.
• Renal/Hepatic Failure: Delays clearance and metabolism of amide LAs.
• Pregnancy: Hormonal changes drastically increase sensitivity to local anaesthetics.

Standard Maximum Doses

The "Safe Injection" Technique Checklist

1. Calculate Before You Draw: Know the patient's weight and calculate the absolute maximum milligram dose before the syringe touches the patient. Communicate this out loud to the team.
2. Add Adrenaline: Where safe (avoid in end-artery digits without WALANT training), use adrenaline (1:100,000 or 1:200,000). It acts as a marker for intravascular injection (a sudden heart rate increase of >10 bpm) and induces local vasoconstriction, drastically slowing systemic absorption.
3. Ultrasound Guidance: Always use ultrasound for regional blocks (e.g., Fascia Iliaca, Sciatic, Popliteal) to visualize the needle tip and the spread of the local anaesthetic away from major vessels.
4. Aspirate Religiously: Aspirate the syringe prior to every single injection. Remember that a negative aspiration does not guarantee you are not in a vessel, as the needle bevel can sit flush against the intimal wall.
5. Fractionate the Dose: Never push 20 mL of local anaesthetic in one go. Inject in 3-5 mL aliquots, pausing for 5-10 seconds to observe the patient and ask about symptoms (tinnitus, metallic taste).
6. Continuous Monitoring: For any high-volume block, keep the patient on continuous pulse oximetry and ECG monitoring for at least 30 minutes post-injection.

Management: The Lipid Rescue Protocol

If a patient exhibits signs of LAST, you must act instantly. STOP INJECTING immediately. CALL FOR HELP (Code Blue / Anaesthetic Emergency). Do not attempt to manage this alone.

Visual Element: A printable "Crisis Checklist" for LAST, designed to be stuck on the theatre wall or kept on your mobile device.

The management of LAST differs significantly from standard Advanced Cardiac Life Support (ACLS). You must focus on preventing hypoxia, aggressively managing seizures, and administering the specific antidote: Intralipid.

1. Airway & Breathing (Prevent Acidosis)

• The Danger of Hypoxia: Hypoxia and acidosis are the enemies in LAST. Acidosis increases cerebral blood flow (delivering more of the toxic drug directly to the brain) and significantly reduces the protein binding of the drug, liberating massive amounts of free, toxic anaesthetic into the plasma.
• Action: Immediately apply 100% Oxygen. Intubate early to secure the airway and heavily hyperventilate the patient to induce a mild hypocapnia and respiratory alkalosis, which helps trap the drug away from the brain and heart.

2. Seizure Control

• Seizures dramatically increase oxygen consumption and lactic acid production, severely worsening the underlying acidosis and accelerating cardiac arrest.
• First Line: Benzodiazepines (e.g., Midazolam 0.1 mg/kg or 2-5mg IV aliquots).
• Avoid: High-dose Propofol. While Propofol stops seizures, it is a potent cardiovascular depressant and will rapidly precipitate cardiovascular collapse in a patient whose heart is already struggling with local anaesthetic blockade.

3. Modified Cardiac Support (ACLS Alterations)

• CPR: Start high-quality CPR immediately if pulses are lost.
• Modifications to standard ACLS:
  • Reduce Adrenaline: Standard 1mg ACLS doses of adrenaline can worsen arrhythmias and metabolic acidosis in LAST. Use highly reduced doses (e.g., < 1 mcg/kg, or 10-100 mcg aliquots).
  • Avoid Vasopressin: It is not recommended in LAST protocols.
  • Avoid Calcium Channel Blockers and Beta Blockers: These will further depress the already stunned myocardium and exacerbate the conduction blockade. Amiodarone is preferred for refractory ventricular arrhythmias.
  • Prepare for Prolonged CPR: Because of the "fast-in, slow-out" kinetics of Bupivacaine, it may take a very long time for the drug to clear from the myocardial receptors. Be prepared to continue CPR for > 1 hour. Full neurological recovery is entirely possible even after prolonged arrest. Consider early escalation to Cardiopulmonary Bypass (CPB) or Extracorporeal Membrane Oxygenation (ECMO) if available.

4. Lipid Emulsion Therapy (The Antidote)

The administration of Intralipid 20% is the cornerstone of LAST resuscitation. You must know where this is kept in your hospital (usually in the operating theatre emergency drug fridge or with the difficult airway trolley).

Mechanism of Action:

1. The "Lipid Sink" Theory: The intravascular lipid emulsion creates a highly lipophilic compartment within the blood. The lipid-soluble local anaesthetic is rapidly drawn out of the brain and myocardial tissue and into this lipid compartment, clearing the receptors.
2. The "Metabolic Shuttle": The heart utilizes fatty acids for energy. Intralipid provides a massive influx of readily available fatty acid substrate to the mitochondria of the stunned myocardium, kickstarting cellular respiration and contractility.

The Lipid Rescue Dosing Protocol (for a 70kg Adult):

• Initial Bolus: 1.5 mL/kg (approximately 100 mL) IV administered rapidly over 1 minute.
• Continuous Infusion: 0.25 mL/kg/min (approximately 1000 mL/hr).
• If the patient remains unstable or goes back into arrest: Repeat the initial bolus (up to a maximum of 3 times) and DOUBLE the infusion rate to 0.5 mL/kg/min.
• Maximum Total Dose: Do not exceed 12 mL/kg (roughly 800-1000 mL total for a standard adult) due to the risk of fat overload syndrome.

5. Post-Resuscitation Care

Even if the patient rapidly recovers following Intralipid administration, they are not out of the woods. Due to tissue absorption, local anaesthetic levels can rise again, leading to a secondary crash.

• Monitoring: The patient MUST be transferred to the Intensive Care Unit (ICU).
• Duration: Monitor for at least 2 to 6 hours after a purely CNS event, and at least 12 to 24 hours following a cardiovascular event or if a long-acting agent like Bupivacaine was used.

Summary

Local Anaesthetic Systemic Toxicity is a rare, terrifying, but entirely reversible cause of perioperative cardiac arrest. As orthopaedic surgeons, we frequently utilize high volumes of local anaesthetics, placing our patients at inherent risk. The difference between a complete neurological recovery and a tragic patient death is the speed of recognition, the avoidance of severe acidosis, and the rapid, unhesitating administration of Lipid Emulsion Therapy.

Key Orthopaedic Takeaways:

• Respect the drug: Always calculate your absolute maximum safe dose based on Ideal Body Weight before you pick up the syringe.
• Listen to the patient: A patient reporting a metallic taste, ringing ears, or sudden anxiety during an ankle block is experiencing LAST until proven otherwise. Stop injecting immediately.
• Know your environment: Before you start a high-volume LIA in a joint replacement, or a wide-awake tendon repair in the emergency department, ask yourself: "Do I know exactly where the Intralipid bag is kept in this facility?"

Dose Calculator

Use our interactive calculator to determine safe maximum limits for your patient based on weight and comorbidities.